Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Jan;79(927):18-24.
doi: 10.1136/pmj.79.927.18.

Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century

M E Begbie  1 , G M F Wallace, C L Shovlin
Affiliations
Review

Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century

M E Begbie et al. Postgrad Med J. 2003 Jan.

Abstract

Hereditary haemorrhagic telangiectasia (HHT) affects one in 5-8000, and no longer can be viewed as solely causing anaemia (due to nasal and gastrointestinal bleeding) and characteristic mucocutaneous telangiectasia. Arteriovenous malformations commonly occur, and in the pulmonary and cerebral circulations demand knowledge of risks and benefits of asymptomatic screening and treatment. HHT is inherited as an autosomal dominant trait and there is no age cut off when apparently unaffected offspring of an individual with HHT can be told they are unaffected. This review focuses on the evolving evidence base for HHT management, issues regarding pregnancy and prothrombotic treatments, and discusses the molecular and cellular changes that underlie this disease.

PubMed Disclaimer

References

    1. J Clin Invest. 1999 Nov;104(10):1343-51 - PubMed
    1. Am J Med. 1954 Jul;17(1):41-9 - PubMed
    1. Pediatr Res. 2000 Jan;47(1):24-35 - PubMed
    1. Am J Gastroenterol. 2000 Feb;95(2):415-8 - PubMed
    1. Am J Pathol. 2000 Mar;156(3):911-23 - PubMed

MeSH terms